E
Eryk Wódkiewicz
Researcher at Nicolaus Copernicus University in Toruń
Publications - 12
Citations - 258
Eryk Wódkiewicz is an academic researcher from Nicolaus Copernicus University in Toruń. The author has contributed to research in topics: Neuroprotection & Resveratrol. The author has an hindex of 7, co-authored 12 publications receiving 123 citations.
Papers
More filters
Journal ArticleDOI
Beneficial Effects of Resveratrol Administration-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions.
Michał Wiciński,Maciej W. Socha,Maciej Walczak,Eryk Wódkiewicz,Bartosz Malinowski,Sebastian Rewerski,Karol Górski,Katarzyna Pawlak-Osińska +7 more
TL;DR: By increasing BDNF (brain-derived neurotrophic factor) serum concentration and inducing NOS-3 (nitric oxide synthase-3) activity resveratrol may have possible therapeutical effects on cognitive impairments and dementias especially in those characterized by defective cerebrovascular blood flow.
Journal ArticleDOI
Liraglutide and its Neuroprotective Properties-Focus on Possible Biochemical Mechanisms in Alzheimer's Disease and Cerebral Ischemic Events
Michał Wiciński,Maciej W. Socha,Bartosz Malinowski,Eryk Wódkiewicz,Maciej Walczak,Karol Górski,Maciej Słupski,Katarzyna Pawlak-Osińska +7 more
TL;DR: Potential mechanisms of liraglutide activity in conditions connected with neuronal damage, with special emphasis on Alzheimer's disease and cerebral ischemia are presented.
Journal ArticleDOI
Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer's Disease and Ischemia-Related Brain Injury.
TL;DR: Potential mechanisms of SGLT-2 inhibitors in conditions connected with neuronal damage, with special emphasis on Alzheimer’s disease and cerebral ischemia are presented and canagliflozin seems to present some cytostatic properties by limiting both human and mice endothelial cells proliferation.
Journal ArticleDOI
Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer's Disease.
Michał Wiciński,Eryk Wódkiewicz,Maciej Słupski,Maciej Walczak,Maciej W. Socha,Bartosz Malinowski,Katarzyna Pawlak-Osińska +6 more
TL;DR: Result of experimental studies may indicate a reducing influence of sitagliptin on inflammatory response within encephalon area, and potential mechanisms of sitgliptin activity in conditions connected with neuroinflammation with special emphasis on Alzheimer's disease.
Journal ArticleDOI
Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis.
Michał Wiciński,Karol Górski,Eryk Wódkiewicz,Maciej Walczak,Magdalena Nowaczewska,Bartosz Malinowski +5 more
TL;DR: The article presents a summary of the studies assessing vasculoprotective effects of vildagliptin with special emphasis on atherogenesis and indicates that affecting the endothelium, inflammation, and lipid metabolism may affect the development of atherosclerosis at its various stages.